Board of Directors
Serge Goldner has founded and managed several companies operating internationally in the fields of Life Sciences and new technologies.
He has more than 15 years of experience in entrepreneurship, business development and corporate finance.
Prior to founding Gour Medical in 2014, he was Chief Financial Officer of Immune Pharmaceuticals, a Nasdaq-listed biotech company (NASDAQ: IMNP). Previously, he was a founder and managing partner of Cukierman & Co Life Sciences, an Israeli-European leader in corporate finance.
Patrick Scherrer is an internationally recognized expert in the management of technological innovation and has over 30 years of experience in the subject.
From 2004 to 2013, he was Managing Director of Widmann Associates, a strategic consulting firm dedicated to supporting companies and venture capital funds, including Vinci Capital, Renaissance and Wellington Partners.
Patrick is also Chairman of the Board of G-Ray Switzerland SA (Neuchâtel, Switzerland), a development stage company with validated core competences in monolithic CMOS integrated pixel array detector technology.
Christian Grandjean is CEO of CMG Capital GmbH, a consulting and investment firm based in Engelberg, Switzerland.
After studying at the Credit Suisse International Banking School in New York, Christian began his professional career at First Boston Corporation in the United States, before joining UBS in Switzerland, where he held various positions.
He then joined Banque Cantonale Vaudoise (Switzerland) as Director.
Christian was also Chief Financial Officer and Chief Operating Officer of Christ Uhren & Schmuck AG and is a director of several companies around the world.